Kotloff KL - Search Results

1

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.

Jackson LA, Frey SE, El Sahly HM, Mulligan MJ, Winokur PL, Kotloff KL, Campbell JD, Atmar RL, Graham I, Anderson EJ, Anderson EL, Patel SM, Fields C, Keitel W, Rouphael N, Hill H, Goll JB. Jackson LA, et al. Among authors: kotloff kl. Vaccine. 2017 Mar 23;35(13):1675-1682. doi: 10.1016/j.vaccine.2017.02.032. Epub 2017 Feb 27. Vaccine. 2017. PMID: 28256358 Clinical Trial.

2

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.

Kotloff KL, Losonsky GA, Nataro JP, Wasserman SS, Hale TL, Taylor DN, Newland JW, Sadoff JC, Formal SB, Levine MM. Kotloff KL, et al. Vaccine. 1995 Apr;13(5):495-502. doi: 10.1016/0264-410x(94)00011-b. Vaccine. 1995. PMID: 7639017 Clinical Trial.

3

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.

Kotloff KL, Nataro JP, Losonsky GA, Wasserman SS, Hale TL, Taylor DN, Sadoff JC, Levine MM. Kotloff KL, et al. Vaccine. 1995 Nov;13(16):1488-94. doi: 10.1016/0264-410x(95)00102-7. Vaccine. 1995. PMID: 8578831 Clinical Trial.

4

Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.

Kotloff KL, Fattom A, Basham L, Hawwari A, Harkonen S, Edelman R. Kotloff KL, et al. Vaccine. 1996 Apr;14(5):446-50. doi: 10.1016/0264-410x(95)00147-s. Vaccine. 1996. PMID: 8735558

5

Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults.

Kotloff KL, Taylor DN, Sztein MB, Wasserman SS, Losonsky GA, Nataro JP, Venkatesan M, Hartman A, Picking WD, Katz DE, Campbell JD, Levine MM, Hale TL. Kotloff KL, et al. Infect Immun. 2002 Apr;70(4):2016-21. doi: 10.1128/IAI.70.4.2016-2021.2002. Infect Immun. 2002. PMID: 11895966 Free PMC article. Clinical Trial.

6

Overview of vaccines and immunisation.

Levine MM, Campbell JD, Kotloff KL. Levine MM, et al. Among authors: kotloff kl. Br Med Bull. 2002;62:1-13. doi: 10.1093/bmb/62.1.1. Br Med Bull. 2002. PMID: 12176846 Review. No abstract available.

7

The causes of hospital admission and death among children in Bamako, Mali.

Campbell JD, Sow SO, Levine MM, Kotloff KL. Campbell JD, et al. Among authors: kotloff kl. J Trop Pediatr. 2004 Jun;50(3):158-63. doi: 10.1093/tropej/50.3.158. J Trop Pediatr. 2004. PMID: 15233192

8

Invasive pneumococcal infections among hospitalized children in Bamako, Mali.

Campbell JD, Kotloff KL, Sow SO, Tapia M, Keita MM, Keita T, Diallo S, Hormazabal JC, Murray P, Levine MM. Campbell JD, et al. Among authors: kotloff kl. Pediatr Infect Dis J. 2004 Jul;23(7):642-9. doi: 10.1097/01.inf.0000130951.85974.79. Pediatr Infect Dis J. 2004. PMID: 15247603

9

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial.

Kotloff KL, Corretti M, Palmer K, Campbell JD, Reddish MA, Hu MC, Wasserman SS, Dale JB. Kotloff KL, et al. JAMA. 2004 Aug 11;292(6):709-15. doi: 10.1001/jama.292.6.709. JAMA. 2004. PMID: 15304468 Clinical Trial.

10

Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults.

Campbell JD, Clement KH, Wasserman SS, Donegan S, Chrisley L, Kotloff KL. Campbell JD, et al. Among authors: kotloff kl. Hum Vaccin. 2007 Sep-Oct;3(5):205-11. doi: 10.4161/hv.3.5.4459. Epub 2007 May 18. Hum Vaccin. 2007. PMID: 17881903 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

349 results

Search Page